US$ 28.08
glp 1 coverage bcbs BC/BS Health Insurance Change in BCBS VT nonsensical rationale for
Description
Probiotics 2 billion CFU of targeted strains to help maintain gut health

DPP-4 inhibition is an interesting line of therapy for treating Type 2 Diabetes Mellitus (T2DM) and is based on promoting the incretin effect

Lot 6040411 COA issued 07/06/2026 Independent lab-verified data for potency, heavy metals & microbiology

Obesity is a significant health concern, affecting millions and placing a heavy burden on healthcare systems

Note: Anti-Obesity GLP-1s Wegovy and Zepbound, Anti-Diabetes GLP-1s Ozempic and Mounjaro Source: IQVIA MAAS Patient Behavior Library Tool